AMAG Pharmaceuticals, Inc. announced the appointment of J. Alan Butcher as executive vice president and chief business officer effective immediately. He reports to William Heiden, president and chief executive officer. In his role at AMAG, Mr. Butcher is responsible for leading the company’s overall business development efforts, with a focus on continuing to expand the portfolio with products that address unmet patient needs. Additionally, he oversees the company's alliance management team, and leads the corporate strategy function in close collaboration with Mr. Heiden, the senior leadership team, and the board of directors. Mr. Butcher brings extensive technical, scientific, strategic, and business development experience to AMAG with his nearly two decades of corporate development work in large and medium-sized pharmaceutical companies. Most recently he served as senior vice president, licensing and business development for Purdue Pharma. Prior to Purdue, he led a global business development team and was responsible for identifying, evaluating and negotiating expansion opportunities at Shire Pharmaceuticals. Earlier in his career, Mr. Butcher conducted scientific research in areas of molecular genetics, virology and cardiovascular drug discovery.